Dr. Noah Biotech Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$7.9M
- Investors
-
12
Dr. Noah Biotech General Information
Description
Developer of an artificial intelligence-based drug discovery platform designed to identify effective drug combinations for rare and complex diseases. The company's platform offers a multi-strategy drug repositioning system, large-scale bio-pharmacological data analysis, and combination drug design capabilities, enabling pharmaceutical companies and researchers to target complex disease pathways and improve therapeutic effectiveness with reduced toxicity.
Contact Information
Website
www.drnoahbiotech.comCorporate Office
- Room 1208, Ace Gwanggyo Tower 2
- 91 Changryong-daero 256beon-gil, Yeongtong-gu
- Suwon, Gyeonggi 16229
- South Korea
Corporate Office
- Room 1208, Ace Gwanggyo Tower 2
- 91 Changryong-daero 256beon-gil, Yeongtong-gu
- Suwon, Gyeonggi 16229
- South Korea
Dr. Noah Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 19-Jun-2022 | $7.9M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 01-Nov-2020 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 13-Aug-2020 | $3.76M | $5.09M | Completed | Clinical Trials - Phase 2 | |
| 1. Seed Round | 07-Dec-2018 | $1.33M | $1.33M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Dr. Noah Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Dr. Noah Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dr. Noah Biotech Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CKD Venture Capital | Corporate Venture Capital | Minority | ||
| Gradient (Korea) | Corporation | Minority | ||
| Korea Venture Investment | Fund of Funds | Minority | ||
| L&S Venture Capital | Venture Capital | Minority | ||
| Pathfinder H | Venture Capital | Minority |
Dr. Noah Biotech FAQs
-
When was Dr. Noah Biotech founded?
Dr. Noah Biotech was founded in 2017.
-
Where is Dr. Noah Biotech headquartered?
Dr. Noah Biotech is headquartered in Suwon, South Korea.
-
What is the size of Dr. Noah Biotech?
Dr. Noah Biotech has 16 total employees.
-
What industry is Dr. Noah Biotech in?
Dr. Noah Biotech’s primary industry is Drug Discovery.
-
Is Dr. Noah Biotech a private or public company?
Dr. Noah Biotech is a Private company.
-
What is Dr. Noah Biotech’s current revenue?
The current revenue for Dr. Noah Biotech is .
-
How much funding has Dr. Noah Biotech raised over time?
Dr. Noah Biotech has raised $13.1M.
-
Who are Dr. Noah Biotech’s investors?
CKD Venture Capital, Gradient (Korea), Korea Venture Investment, L&S Venture Capital, and Pathfinder H are 5 of 12 investors who have invested in Dr. Noah Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
